UC researchers study processes that cause breast cancer recurrence, spread

National Cancer Institute grant allows researchers to look at targeted treatments for breast cancer

One in eight women will be diagnosed with breast cancer in their lifetimes. Recurrence and spread are the biggest contributors to the death of these women.

That’s why Susan Waltz, professor in the UC department of cancer biology, is teaming up with other researchers at UC, Cincinnati Children’s Hospital Medical Center and the University of Kentucky to study the processes that cause these events to occur — and ways to both target and stop them.

The National Cancer Institute recently awarded this collaborative team a $500,000 yearly grant for the next five years to do just that.

Susan Waltz, PhD

Susan Waltz, professor in the UC department of cancer biology. Photo credit: Colleen Kelley/UC Creative + Brand

“The focus of this grant is understanding why some breast cancers come back after initial treatment and metastasize and others don’t,” says Waltz, the principal investigator on the study. “We identified two genes (RON and DEK) which are both found in human breast cancers. When both of these genes combined are seen in breast cancers, they are highly predictive of the cancers recurring and spreading.”

She says the teams are trying to uncover reasons these genes make breast cancer so aggressive and discover whether or not this knowledge can be used to predict which tumors are more likely to come back.

“We hope this will help us identify new vulnerabilities in these cancers — an Achilles’ heel, if you will — that can be used for the treatment of these aggressive cancers,” she says. “Our new data suggest that these genes rewire breast cancer cells to support unique energy needs of the cells by increasing cholesterol and glucose use required for tumors to grow and spread. 

“In this study, we hope to map, at high resolution at the atomic level, the unique energy network driven by these two genes, with the goal of using this information to identify key nutrients that might both predict and be used to block breast cancers from coming back or metastasizing,” Waltz added.

“This could provide new ways to identify and treat potentially aggressive breast cancers at early stages, increasing survival and improving lives.”

Featured photo courtesy of Drew Hays/Unsplash

Next Lives Here

The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.

Related Stories

1

Cincinnati researchers want to know if MRIs can work better

June 28, 2024

WVXU and the Cincinnati Business Courier highlighted a new collaboration between the University of Cincinnati College of Medicine, UC Health GE HealthCare, JobsOhio, REDI Cincinnati and Cincinnati Children’s to create an MRI Research and Development Center of Excellence located on UC’s medical campus.

3

UC opens Blood Cancer Healing Center

June 28, 2024

Media outlets including WLWT, Local 12, Spectrum News, the Cincinnati Enquirer and Cleveland.com highlighted the opening of the University of Cincinnati Cancer Center's Blood Cancer Healing Center.

Debug Query for this